An accomplished leader with over 15 years of experience driving innovation in Animal Health. As Head of External Innovation at Elanco Animal Health since 2022, Steve leads a team responsible for identifying and evaluating novel animal health solutions, from early discovery to late-stage development. He collaborates with pharmaceutical companies, biotech firms, and universities, securing cutting-edge advancements for Elanco. Previously, Steve contributed significantly to Elanco’s success by leading key R&D programs, including Credelio® and Imvixa®. His career began as a medicinal chemist at Novartis Animal Health, following a postdoctoral fellowship at Stanford University and earning a PhD in organic chemistry from the University of Basel. He has extensive experience spearheading global projects from discovery through development and regulatory submission.